HNRNPK and breast carcinoma: The phosphorylation of hnRNPK at serine 379 increased the expression of migratory molecules β-catenin and matrix metalloproteinase MMP12, thereby enhancing metastasis in the breast cancer cell line MDA-MB-231 [129].